tert-Butyl ((cis-4-aminocyclohexyl)methyl)carbamate

Catalog No. :
ACSWOI835
CAS No. :
866548-92-7
Molecular Formula :
C12H24N2O2
Molecular Weight :
228.34

IUPAC Name:tert-butyl (((1s,4s)-4-aminocyclohexyl)methyl)carbamate

tert-Butyl ((cis-4-aminocyclohexyl)methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$69.00Login to see priceIn stockIn stock
1g97%$173.00Login to see priceIn stockIn stock
5g97%$517.00Login to see priceIn stockIn stock
25g97%$2507.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((cis-4-aminocyclohexyl)methyl)carbamate
IUPAC Nametert-butyl (((1s,4s)-4-aminocyclohexyl)methyl)carbamate
MDL No.MFCD22395596
Molecular FormulaC12H24N2O2
Molecular Weight228.34
SMILESO=C(OC(C)(C)C)NC[C@H]1CC[C@@H](N)CC1
InChI KeyHMMYZMWDTDJTRR-AOOOYVTPSA-N
Synonym192323-07-2 | 866548-92-7 | CIS-4-(BOC-AMINOMETHYL)CYCLOHEXYLAMINE | TERT-BUTYL TRANS-4-AMINOCYCLOHEXYLMETHYLCARBAMATE | 296270-94-5 | tert-Butyl ((trans-4-aminocyclohexyl)methyl)carbamate | 4-(Boc-aminomethyl)-cyclohexylamine | tert-Butyl ((cis-4-aminocyclohexyl)methy
CAS No.866548-92-7
PubChem CID21882540

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSWOI835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSWOI835 route product structure diagram
    ACSWOI835866548-92-7 In Stock
Inquiry

2. ACSWOI835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSWOI835 route product structure diagram
    ACSWOI835866548-92-7 In Stock
Inquiry

Comments (0)